DEUTSCHE BANK AG\ - MATINAS BIOPHARMA HLDGS INC ownership

MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 49 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of MATINAS BIOPHARMA HLDGS INC
ValueSharesWeighting
Q1 2019$275,000
+1347.4%
252,968
+1077.7%
0.00%
Q3 2018$19,000
-64.2%
21,480
-82.8%
0.00%
Q2 2018$53,000
-22.1%
125,028
+39.7%
0.00%
Q1 2018$68,000
-60.2%
89,525
-39.5%
0.00%
Q4 2017$171,000
+155.2%
148,042
+184.8%
0.00%
Q3 2017$67,000
-33.7%
51,988
-13.7%
0.00%
Q2 2017$101,00060,2390.00%
Other shareholders
MATINAS BIOPHARMA HLDGS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Alliance Wealth Management Group 400,826$465,0000.23%
Yellowstone Partners, LLC 143,914$167,0000.09%
IFP Advisors, Inc 251,172$291,0000.01%
HYMAN CHARLES D 79,800$93,0000.01%
Virtu Financial LLC 106,146$123,0000.01%
Raymond James Financial Services Advisors, Inc. 659,890$765,0000.01%
Tower Research Capital LLC (TRC) 21,181$25,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 189,000$219,0000.00%
BlackRock Inc. 2,530,508$2,935,0000.00%
Bank of New York Mellon Corp 175,325$203,0000.00%
View complete list of MATINAS BIOPHARMA HLDGS INC shareholders